Synergistic Antitumor Effect of Doxorubicin and Tacrolimus (FK506) on Hepatocellular Carcinoma Cell Lines
Figure 4
Significant cytokine levels (pg/mL) evaluated in cellular supernatant untreated and after treatment with doxorubicin (0.85 μM) and tacrolimus (0.052 μM) and cotreatment (0.42 μM dox plus 0.026 μM tacr).
